We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.
Newsroom
Newsroom articles are published by leading news agencies. Hargreaves Lansdown is not responsible for an article's content and its accuracy. We may not share the views of the author.
HL Podcast
HL Insight
The healthcare sector is enormous, absorbing over 10% of the economic output of many developed nations. We take a closer look at the risks and opportunities to watch out for.
This article isn’t personal advice. If you’re not sure whether an investment is right for you please seek advice. If you choose to invest the value of your investment will rise and fall, so you could get back less than you put in.
Published on 30 November 2023
It was correct at the time of publishing. Our views and any references to tax, investment and pension rules may have changed since then.
The healthcare sector covers the huge range of activities needed to deliver medical care globally. Things like diagnostic tools and the wide selection of pharmaceuticals and medical devices used to treat patients.
Then there are research organisations and insurers. This universe also includes privately-run care facilities, as well as medical distributors and pharmacies.
Past performance isn’t a guide to the future. Source: Refinitiv Eikon, 26 November 2023.
The pandemic has been hugely disruptive for the healthcare sector. It caused significant delays in clinical trials pipelines and an unprecedented backlog in patient care. Made even worse by difficulties in the supply chain.
So maybe it’s no surprise that the sector underperformed at the peak of the pandemic. But it also let certain
Read more on hl.co.uk